HARMONY Experts will present and participate in the Symposium of the European LeukemiaNet, organized in-person in Mannheim, Germany on 18 April 2022.
ELN is a publicly funded research network of excellence that aims to improve the treatment of leukemia through coordinated research efforts across Europe. ELN is a HARMONY and HARMONY PLUS Partner.
More information to follow.
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
The HARMONY Alliance (HARMONY and HARMONY PLUS) is a public-private European Network of Excellence for Big Data in Hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies.
- HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
- HARMONY: 100+ Partners and Associated Members, including 9 European Patient Organizations from 18 countries. Budget: 40 million | January 2017- June 2023
- HARMONY PLUS: 39 Partners from 10 countries. Budget 12 million. Period: October 2020 – September 2023
Receive the latest news. Click here to subscribe!